Intelligence Feed

Articles, research, videos and community discussion.

ryguy98

the weird part of peptide testing is that a sample can pass the most commonly advertised tests and still leave some pretty important questions unanswered. mass spec can confirm the expected molecular weight, and hplc can show a major peak, but neither one automatically proves the full amino acid sequence, correct folding, biological activity, sterility, or low endotoxin levels. that doesn’t mean the results are useless. it just means “99% purity” is often treated like a complete quality verdict when it’s really only one measurement under one method. even the hplc number can vary depending on the column, solvent system, reference standard, and how the lab reports impurities. what i’m noticing in the industry is that testing is being used more as a marketing badge than as a risk map. a serious report should make it clear what was actually tested, what method was used, the detection limits, and what was not tested. otherwise people end up comparing a two-page lab summary with a full analytical package as if they’re equivalent.

395 views comments
Comments 20
youngpixel

Identity isn't the same as usability. LC-MS can confirm the expected molecular mass, and HPLC can estimate purity, but neither tells you whether a peptide has meaningful endotoxin contamination, residual solvents, particulates, or problems from aggregation. For research material, what testing panel do you consider the practical minimum beyond identity and chromatographic purity? I’m especially curious whether people prioritize endotoxin and residual-solvent testing, or only add those when the route of administration makes them relevant.

431 views comments
Comments 35